We are live on ! Find out more
IMVT icon

Immunovant
IMVT

14 hedge funds and large institutions have $36.6M invested in Immunovant in 2019 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,100% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 1

965% more capital invested

Capital invested by funds: $3.44M → $36.6M (+$33.1M)

367% more funds holding

Funds holding: 3 → 14 (+11)

23.16% more ownership

Funds ownership: 2.43% → 25.6% (+23%)

Holders
14
Holders Change
+11
Holders Change %
+366.67%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
1
Reduced
–
Closed
1
Calls
$248K
Puts
–
Net Calls
+$248K
Net Calls Change
+$248K

Top Buyers

Rank Fund Capital Flow
1
GL
Governors Lane
New York
+$8.17M
2
6CM
683 Capital Management
New York
+$7.9M
3
DKCM
Davidson Kempner Capital Management
New York
+$5.18M
4
BFM
Boothbay Fund Management
New York
+$4.31M
5
JGC
J. Goldman & Co
New York
+$2.96M

Top Sellers

Rank Fund Capital Flow
1
SM
Scoggin Management
New York
-$2.45M
Name Holding Trade Value Shares
Change 		Change in
Stake
GL
1
Governors Lane
New York
$8.21M +$8.17M +828,004 New
6CM
2
683 Capital Management
New York
$8.02M +$7.9M +800,000 New
DKCM
3
Davidson Kempner Capital Management
New York
$5.13M +$5.18M +524,400 New
BFM
4
Boothbay Fund Management
New York
$4.33M +$4.31M +436,264 New
JGC
5
J. Goldman & Co
New York
$3.01M +$2.96M +300,000 New
WAM
6
Wolverine Asset Management
Illinois
$1.76M +$1.74M +176,157 New
Walleye Trading
7
Walleye Trading
New York
$1.28M +$1.29M +130,727 New
HIM
8
HGC Investment Management
Ontario, Canada
$1.07M +$1.05M +106,627 New
KPF
9
K2 Principal Fund
Ontario, Canada
$1.01M +$1.02M +102,926 New
MP
10
Mangrove Partners
Connecticut
$1M +$987K +100,000 New
BCM
11
Basso Capital Management
Connecticut
$746K +$735K +74,455 New
WAM
12
Weiss Asset Management
Massachusetts
$503K +$3.95K +400 +0.8%
MF
13
Magnetar Financial
Illinois
$500K – – –
PAM
14
Panagora Asset Management
Massachusetts
$8K +$8.09K +820 New
SM
15
Scoggin Management
New York
– -$2.45M -250,000 Closed

IMVT Hedge Fund Activity: Q3 2019 in Review

14 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Immunovant (IMVT) for Q3 2019, worth a combined $36.6M — up 965% from $3.44M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new IMVT positions and 1 closed out — a net gain of 11 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Governors Lane, opening a new position worth an estimated $8.17M. The largest seller was Scoggin Management, exiting entirely with an estimated $2.45M sold.

  • 14 institutional investors held Immunovant (IMVT) as of Q3 2019, up from 3 in Q2 2019.
  • Funds reported $36.6M of Immunovant stock for Q3 2019, up 965% quarter-over-quarter.
  • 12 funds opened new Immunovant positions in Q3 2019 and 1 closed out, a net change of +11 holders.
  • The largest Immunovant buyer in Q3 2019 was Governors Lane, an estimated $8.17M added.
  • The largest Immunovant seller in Q3 2019 was Scoggin Management, an estimated $2.45M sold.

Based on aggregated 13F filings for Q3 2019.